C-Telopeptide of Type I Collagen (CTX)
C-telopeptide of type I collagen (CTX) is a fragment released into the blood when bone is broken down and resorbed. It is one of the most widely used markers of bone breakdown.
CTX is a bone turnover marker that reflects the resorption side of remodeling, how quickly old bone is being dissolved. Clinicians use it mainly to monitor bone health and to check whether medications that slow bone loss, such as those used for osteoporosis, are working as intended. It is usually followed as a trend rather than judged from one reading, and timing and fasting can affect the result.
A higher CTX can indicate faster bone breakdown, which may occur with untreated bone loss, certain conditions, or natural variation. Because CTX rises and falls with time of day and recent meals, a single elevated value should be interpreted cautiously and in context. Your clinician looks at the pattern alongside your history and other results.
A lower CTX often reflects reduced bone breakdown, which is frequently the intended effect of anti-resorptive osteoporosis treatment. In that setting a fall in CTX can be a reassuring sign the medication is working.
There is no single ideal number, and CTX is most meaningful tracked over time and against any treatment you are taking. Your clinician can explain what your result means for you.
Sources
Educational context only, not medical advice or a diagnosis. Reference ranges vary by lab, age and sex; always discuss your results with a clinician.